Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS

On behalf of the TECOS Study Group

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS'. Together they form a unique fingerprint.

Medicine & Life Sciences